Company that has re-engineered the way prescriptions are filled and delivered also setting fundraising records on SeedInvest.
Orange County, CA – NowRx, the company that re-engineered the way prescriptions are filled and delivered, announced that since deploying its QuickFill pharmacy automation technology in April 2019, its intelligent auto-coupon software feature has saved customers over $1 million in total. The company also announced that it continues to set fundraising records on SeedInvest, with over $10 million raised from small investors who believe in NowRx’s disruptive business model.
QuickFill, NowRx's proprietary pharmacy management software, identifies medications by industry code and automatically matches it with available manufacturer coupons. NowRx's automated, end-to-end robotic dispensing system then fills the medication with the coupon applied, allowing customers to save on their medications.
"With our system, the coupon is applied automatically and the consumer gets the savings without having to remember it or to take any extra steps to activate it," says Cary Breese, founder and CEO of NowRx. “Since being deployed, over 6K prescriptions have had manufacturer coupons automatically applied by NowRx's Quickfill system.”
This month NowRx set another fundraising record on SeedInvest, surpassing $5 million, with the most investments currently on SeedInvest: https://www.
NowRx has same-day delivered over one hundred thousand prescriptions and OTC medications door-to-door through its tech-enabled, robotics-driven pharmacies in Orange County, San Jose, Mountain View and Burlingame, that are able to do the work of 10+ pharmacies. NowRx is achieving record customer ratings and prescription fill numbers with a 90% satisfaction rating on over 100,000 prescriptions for over 20,000 customers – from more than 4,500 physicians.
NowRx saves consumers countless hours wasted waiting in lines at the pharmacy and, by providing consumers with a convenient, free and same-day way to receive their prescriptions, NowRx also helps solve the challenge of prescription non-adherence, an often life and death issue that is responsible for adding over $290 billion in additional cost to the US healthcare system.
This Company’s profile and accompanying offering materials may contain forward-looking statements and information relating to, among other things, the Company, its business plan and strategy, and its industry. These statements reflect management’s current views with respect to future events based on information currently available and are subject to risks and uncertainties that could cause the Company’s actual results to differ materially. Investors are cautioned not to place undue reliance on these forward-looking statements as they are meant for illustrative purposes and they do not represent guarantees of future results, levels of activity, performance, or achievements, all of which cannot be made. The Company does not undertake any obligation to revise or update these forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.
NowRx Media Contacts: